MyPeptideMatch
Diet & Wellness Weight Loss Clinic operates as a physician-supervised telehealth practice serving patients throughout Tennessee, with a primary focus on metabolic health optimization and medically managed weight reduction. The clinic provides access to three FDA-approved GLP-1 receptor agonist medications—Liraglutide, Semaglutide, and Tirzepatide—each selected based on individual patient metabolic profiles, weight loss goals, and medical history. Operating exclusively through secure telehealth platforms, the Memphis-based clinic eliminates geographic barriers for Tennessee residents seeking evidence-based pharmacological intervention for obesity and metabolic dysfunction.
The medication protocols at Diet & Wellness Weight Loss Clinic center on incretin-based therapies that modulate glucose-dependent insulin secretion and appetite regulation. Liraglutide, administered as a daily subcutaneous injection, serves patients requiring gradual dose titration and those with specific cardiovascular considerations. Semaglutide, available in weekly injection form, provides extended duration of action for patients seeking less frequent dosing schedules. Tirzepatide represents the clinic's dual GIP/GLP-1 receptor agonist option, prescribed for patients who may benefit from enhanced metabolic effects through combined incretin pathway activation. Each medication requires individualized dosing strategies, with physicians adjusting protocols based on patient response, tolerability, and metabolic markers tracked through regular virtual consultations.
The clinical team conducts comprehensive metabolic assessments prior to initiating any pharmacotherapy, evaluating factors including baseline hemoglobin A1c, fasting glucose, lipid panels, thyroid function, and body composition metrics when available. Physicians review contraindications specific to GLP-1 therapies, including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. The telehealth model includes structured follow-up intervals—typically every four weeks during titration phases—allowing providers to monitor for common adverse effects such as gastrointestinal symptoms, adjust dosing trajectories, and reinforce nutritional strategies that complement pharmacological intervention. Patients receive detailed injection technique training, medication storage guidelines, and protocols for managing potential side effects.
Diet & Wellness Weight Loss Clinic structures its programs to extend beyond prescription management, incorporating nutritional counseling that addresses macronutrient distribution, meal timing strategies, and sustainable dietary patterns compatible with GLP-1 therapy. The clinic's approach recognizes that these medications reduce appetite and slow gastric emptying, requiring patients to adapt eating behaviors to smaller portion sizes and nutrient-dense food selections. Virtual consultations allow Tennessee patients from Memphis, Nashville, Knoxville, Chattanooga, and rural communities to access specialized obesity medicine without travel requirements, with prescriptions transmitted electronically to patients' preferred pharmacies. The clinic maintains a 4.7-star rating across 45 Google reviews, reflecting patient experiences with accessibility, provider responsiveness, and outcomes achieved through the telehealth delivery model.
The Memphis clinic differentiates itself through its exclusive focus on GLP-1 and dual incretin therapies rather than offering a broad menu of unrelated treatments, allowing the medical team to develop deep expertise in these specific pharmacological mechanisms. Patients undergo regular metabolic monitoring, with physicians requesting updated laboratory work at defined intervals to assess glycemic control improvements, lipid profile changes, and liver function. The telehealth structure provides flexibility for working professionals and individuals with mobility limitations, while the Tennessee-only licensure ensures providers maintain familiarity with state-specific insurance landscapes, compounding pharmacy networks, and prior authorization processes. For patients who achieve target weight reduction, the clinic offers maintenance protocols and discussions regarding duration of therapy, recognizing that obesity represents a chronic metabolic condition often requiring extended pharmacological management to sustain results.
Dr. Miller, MD
Physician
Dr. Miller is a licensed physician providing physician-guided weight loss and metabolic health care aligned with recognized clinical guidelines. He received his medical degree from Columbia University and completed postgraduate training at Washington University in St. Louis. Dr. Miller conducts personalized medical evaluations and may prescribe treatment when appropriate.
Dr. Niles, MD
Physician
Dr. Niles is a licensed physician with over 30 years of clinical experience who provides physician-guided weight loss consultations centered on personalized care. She evaluates each patient’s medical history and individual goals to determine appropriate treatment options when indicated.
Dr. Krasne, MD
Physician
Dr. Krasne is a board-certified physician who conducts personalized weight loss evaluations and provides physician-guided care. He completed his medical training at the University of Florida and the University of Miami Miller School of Medicine, with residency completed in 2017. When clinically appropriate, he may prescribe GLP-1 medications based on individual health needs.
Dr. Bugailiskis, MD
Physician
Dr. Bugailiskis is a licensed physician who provides personalized, physician-guided weight loss care. She earned her medical degree from the University of Illinois at Chicago and works with patients to evaluate their health history, goals, and clinical needs when determining appropriate treatment options.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
